Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial Assessing the Safety and Effectiveness of Orthokeratology Lenses in Patients With Myopia and Myopic Astigmatism
Sponsor: Menicon Co., Ltd.
Summary
This is a prospective, multi-centre, single-arm clinical trial to evaluate the effectiveness and safety of MCOK-01 lenses in patients with myopia and myopic astigmatism who need dioptric correction. A maximum number of 220 participants are planned to be enrolled , with a minimum of 150 planned to complete the trial (30% dropout). All participants will be enrolled in Australia. Enrolled participants will wear the lenses every night for up to 12 months, removing them upon waking. 8 follow up visits will be completed during treatment, after: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months of wearing the lenses.
Official title: A Prospective, Multi-centre, Single-Arm Clinical Trial of Orthokeratology Lenses (MCOK-01) in Subjects With Myopia and Myopic Astigmatism
Key Details
Gender
All
Age Range
6 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2025-07-01
Completion Date
2026-12-01
Last Updated
2025-07-02
Healthy Volunteers
No
Conditions
Interventions
MCOK-01
The investigational device is a Rigid Gas Permeable contact lenses for orthokeratology. MCOK-01 applied the reverse geometry design and adopted the lens material which possesses the highest oxygen permeability among all the materials for orthokeratology lens.
Locations (4)
Eyecare Kids
Hillsdale, New South Wales, Australia
UNSW School of Optometry and Vision Science
Sydney, New South Wales, Australia
Queensland University of Technology Optometry and Vision Science
Kelvin Grove, Queensland, Australia
The University of Melbourne Department of Optometry and Vision Sciences
Carlton, Victoria, Australia